Tag Archives: Revna Biosciences

Revna Biosciences receives historic FDA approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa

Dr Derrick Akpalu,   Ghana-based precision medicine company Revna Biosciences (RevnaBio) has received historic approval from the Food and Drugs Authority of Ghana (FDA) to use the NeuMoDx™ 96 diagnostics platform supplied by the global biotech company QIAGEN.   The registration comes in addition to FDA permissions for RevnaBio to …

Read More »